Loading...
Market
Where will Luminate Medical's Lily helmet receive regulatory approval by the end of 2024?
2
Resolution / Starting Odds
Only in the US • 25%
Only in the EU • 25%
In both the US and the EU • 25%
Neither • 25%
Official announcements from regulatory bodies and Luminate Medical press releases
Story
Luminate Medical Raises $15M Series A to Advance Hair-Saving Chemo Helmet and At-Home Cancer Care
Sep 19, 2024, 08:55 AM
Luminate Medical, a Galway-headquartered medtech company, has raised $15 million in a Series A funding round to support its innovative cancer care solutions. The funding will help bring their hair-saving chemo helmet, Lily, closer to release. This helmet aims to prevent hair loss, a common side effect of chemotherapy, thereby improving the quality of life for cancer patients. The new funding will also be directed toward expanding at-home cancer care services, making treatment more accessible and comfortable for patients. Aaron Hannon, a key figure in the company, was mentioned in the announcement by TechCrunch.
View original story
Similar markets
FDA (USA) • 25%
EMA (EU) • 25%
MHRA (UK) • 25%
Other • 25%
Only FDA • 25%
FDA and EMA • 25%
FDA, EMA, and MHRA • 25%
None • 25%
Yes • 50%
No • 50%
Japan • 25%
USA • 25%
EU • 25%
Other • 25%
Yes • 50%
No • 50%
